| Name | Title | Contact Details |
|---|
Lasergen is an emerging biotechnology company focused on commercializing novel technologies for DNA sequencing. Our expertise in nucleotide chemistry and next-generation sequencing has led to a number of key discoveries resulting in both game-changing sequencing chemistry (Lightning Terminators™) and a more accurate sequencing platform. While focusing on the development of current cutting-edge technology, our continued drive for innovation and extensive sequencing knowledge allows us to rapidly evolve and keep pace with fast-changing advances in the sequencing industry.
M*Modal offers a new breed of speech understanding applications. Our hosted conversational documentation services help healthcare providers capture clinical information from dictation and transform it directly into accessible, retrievable, and shareable electronic files. M*Modal serves hospitals, medical clinics, and medical transcription companies representing a transaction volume of more than 400 million dictation minutes a year.
Mazor Robotics Renaissance Guidance System is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures that may reduce fluoroscopy. It is the only mechanical guidance system for spine surgery with FDA clearance and CE marking. Renaissance has been used in thousands of spine procedures worldwide ranging from minimally-invasive surgery to scoliosis and other complex spinal deformity cases.
Responselink is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anavasi Diagnostics is a medical technology company focused on saving lives by developing novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology. It was founded by world-leading university researchers, top medical device and clinical diagnostics engineering and design executives, manufacturing experts and a former Microsoft software veteran. Throughout their careers, the team has altogether been responsible for the introduction of more than forty medical/diagnostic products and over 350 peer-reviewed research publications.